GL1X · GenesisL1 explorer

Research workbench

PARP1 catalytic domain in complex with a selective pyridine carboxamide-based inhibitor (compound 22)

Analyse PARP1 catalytic domain in complex with a selective pyridine carboxamide-based… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7ONT
Type
protein
Length
700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30, 2.4.2.-
UniProt
P09874
Ligands
VKQ, SO4
Pockets
9 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein35040% helix, 25% strandP09874

Ligands and binding sites

  • VKQ · 5-[4-[(3-ethyl-2-oxidanylidene-1~{H}-quinolin-7-yl) methyl]piperazin-1-yl]-~{N}-methyl-pyridine-2-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18390.810.8487VKQ, SO4
23490.780.8835VKQ
3920.490.8217empty
41060.430.7816empty
5630.390.7918empty

Interfaces

1 interface between chains.

  • A–B · 766 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 7ONT · PARP1 catalytic domain in complex with a selective pyridine carboxamide-based inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.